On the morning of February 13, the Clinical Study Summary and Data Unblinding Meeting for the aesthetic microneedling project undertaken by our company was successfully held. This project, commissioned by Cellah Medical Co., Ltd. (Korea), is a pivotal clinical trial for an aesthetic medical device conducted jointly at West China Hospital of Sichuan University and Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine. The trial aimed to evaluate the safety and efficacy of the radiofrequency microneedling system (Model: D1) in adults with atrophic acne scars.
The clinical trial results showed that the radiofrequency microneedling system achieved the predefined safety and efficacy endpoints for improving atrophic acne scars, meeting the aesthetic needs of adult patients with this condition.
The successful completion of this project marks a significant step forward in our in‑depth collaboration with top‑tier domestic medical institutions and an overseas enterprise. It also demonstrates our professional service capabilities and resource integration strength in the clinical research of aesthetic medical devices.
